definiens: shall mean ( a ) at any time during the Novartis Exclusivity Term, any Target which is(i ) identified by [COMPANY] pursuant to Section 3.7(a ) which is not a Blocked Target, ( ii ) submitted to Novartis pursuant toTakeda ’s exercise of the Designated Target Option pursuant to Section 3.9, and ( iii ) rejected or waived by Novartis, asevidenced by [COMPANY] ’s written notice to [COMPANY] pursuant to Section 3.9 ; and ( b ) at any time following the end of theNovartis Exclusivity Term, any Target identified by [COMPANY] pursuant to Section 3.7(a ) which is not a Blocked Target . Forthe avoidance of doubt, ( x ) if [COMPANY] selects any Target prior to the end of the Novartis Exclusivity Term for submissionto Novartis, but such Target is not submitted to Novartis until after the end of the Novartis Exclusivity Term, or ( y ) ifTakeda selects any Target prior to the end of the Novartis Exclusivity Term for submission to Novartis and such Targetis submitted to Novartis prior to the end of the Novartis Exclusivity Term, but the time period during which Novartis isobligated to reply does not end until after the end of the Novartis Exclusivity Term, then such Target shall not bedeemed a hereunder until such Target has been actually rejected or deemed waived by Novartispursuant to the terms of the Novartis Agreement